Cost-effective osteoporosis treatment thresholds: The United States perspective

Osteoporosis International

Volumn 19, Issue 4, 2008, Pages 437-447

  Tosteson, A N A ^a   Melton III, L J ^b   Dawson Hughes, B ^c   Baim, S ^d   Favus, M J ^e   Khosla, S ^b   Lindsay, R L ^f  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b MAYO CLINIC   (United States)

^c TUFTS UNIVERSITY   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f HELEN HAYES HOSPITAL   (United States)

Author keywords

Cost effectiveness; National Osteoporosis Foundation; Osteoporosis; Practice guidelines; World Health Organization

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; COST EFFECTIVENESS ANALYSIS; DRUG COST; ETHNICITY; EUROPEAN AMERICAN; FEMALE; FOREARM FRACTURE; GENDER; HIP FRACTURE; HISPANIC; HUMAN; INCIDENCE; LEG FRACTURE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PATIENT COMPLIANCE; PELVIS FRACTURE; PRIORITY JOURNAL; PROBABILITY; QUALITY OF LIFE; RACE; RIB FRACTURE; RISK REDUCTION; SHOULDER FRACTURE; SPINE FRACTURE; UNITED STATES; AGE; ALGORITHM; COST BENEFIT ANALYSIS; ECONOMICS; FRACTURE; HEALTH CARE COST; MIDDLE AGED; QUALITY ADJUSTED LIFE YEAR; STATISTICAL MODEL; STATISTICS; TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALGORITHMS; COST-BENEFIT ANALYSIS; FEMALE; FRACTURES, BONE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; OSTEOPOROSIS; PROBABILITY; QUALITY-ADJUSTED LIFE YEARS; TIME FACTORS; UNITED STATES;

EID: 46649091797     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0550-6     Document Type: Article

References (41)

1. Kanis JA, Borgström F, De Laet C, Johansson H, Johnell O, Jönsson B, Odén A, Zethraeus N, Pfleger B, Khaltaev N (2005) Assessment of fracture risk. Osteoporos Int 16:581-589
2. Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C, Delmas P, Eisman J, Johnell O, Jönsson B, Melton L, Odén A, Papapoulos S, Pols H, Rizzoli R, Silman A, Tenenhouse A, International Osteoporosis F, National Osteoporosis F (2002) A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 13:527-536 (Pubitemid 34790624)
3. Anonymous (1998) Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Introduction. Osteoporos Int 8(Suppl 4):S7-80
4. Department of Health and Human Services. (2004) In Bone Health and Osteoporosis A Report of the Surgeon General. Rockville, MD.
5. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465-475 (Pubitemid 46797130)
6. Sonnenberg FA, Beck JR (1993) Markov models in medical decision making: a practical guide. Med Decis Mak 13:322-338
7. Kanis JA, Odén A, Johnell O, Jönsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417-427 (Pubitemid 32606468)
8. Kanis JA, Borgström F, Zethraeus N, Johnell O, Odén A, Jönsson B (2005) Intervention thresholds for osteoporosis in the UK. Bone 36:22-32
9. Kanis JA, Johnell O, Odén A, Borgström F, Johansson H, De Laet C, Jönsson B (2005) Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int 16:6-14 (Pubitemid 40193214)
10. Haentjens P, Autier P, Collins J, Velkeniers B, Vanderschueren D, Boonen S (2003) Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis. J Bone Jt Surg Am Vol85-A:1936-1943 (Pubitemid 37259729)
11. Kanis JA, Johnell O, De Laet C, Johansson H, Odén A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375-382 (Pubitemid 38953182)
12. Melton LJ III, Crowson CS, O'Fallon WM (1999) Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 9:29-37
13. United States Census Bureau (2005) State & County QuickFacts. (Accessed at http:quickfacts.census.gov/qfd/states/27/27109.html)
14. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761-1767
15. Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G, Osteoporosis Methodology G, The Osteoporosis Research Advisory G (2002) Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23:508-516
16. Borgström F, Johnell O, Kanis JA, Jönsson B, Rehnberg (2006) At what hip fracture risk is it cost-effective to treat? International Intervention thresholds for the treatment of osteoporosis. Osteoporos Int 17:1459-1471
17. Tosteson AN, Jönsson B, Grima DT, O'Brien BJ, Black DM, Adachi JD (2001) Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporos Int 12:849-857 (Pubitemid 33086272)
18. Badamgarav E, Fitzpatrick LA (2006) A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence.[comment]. Mayo Clin Proc 81:1009-1012
19. Tosteson AN (2003) Characterizing preferences for health outcomes in economic evaluations. J Rheumat Suppl 68:15-18 (Pubitemid 37549315)
20. Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG (2006) Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Mak 26:391-400 (Pubitemid 44050843)
21. Gabriel SE, Tosteson AN, Leibson CL, Crowson CS, Pond GR, Hammond CS, Melton LJ 3rd (2002) Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 13:323-330
22. Arias E, Anderson RN, Kung HC, Murphy SL, Kochanek KD (2003) Deaths: final data for 2001. Natl Vital Stat Rep 52:1-115
23. Melton LJ, III (2003) Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res 18:1139-1141
24. Fisher ES, Baron JA, Malenka DJ, Barrett JA, Kniffin WD, Whaley FS, Bubolz TA (1991) Hip fracture incidence and mortality in New England. Epidemiology 2:116-122
25. Miller CW (1978) Survival and ambulation following hip fracture. J Bone Jt Surg Am Vol60:930-934
26. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ 3rd (1993) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001-1005
27. Katelaris AG, Cumming RG (1996) Health status before and mortality after hip fracture. Am J Public Health 86:557-560 (Pubitemid 26125039)
28. Keene GS, Parker MJ, Pryor GA (1993) Mortality and morbidity after hip fractures.[see comment]. BMJ 307:1248-1250
29. Poor G, Atkinson EJ, O'Fallon WM, Melton LJ, III (1995) Determinants of reduced survival following hip fractures in men. Clin Orthop Relat Res 260-265
30. Magaziner J, Lydick E, Hawkes W, Fox KM, Zimmerman SI, Epstein RS, Hebel JR (1997) Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health 87:1630-1636 (Pubitemid 27465238)
31. Melton LJ III, Therneau TM, Larson DR (1998) Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival. Osteoporos Int 8:68-74
32. Gold M, Siegel J, Russell L, Weinstein M (1996) Cost-effectiveness in Health and Medicine. Oxford University Press, New York
33. Center for the Evaluation of Value and Risk in Health (2007) CEA Registry. http://www.tufts-nemc.org/cearegistry/ Institute of Clinical Research and Health Policy Studies, Tufts New England Medical Center
34. Stone PW, Teutsch S, Chapman RH, Bell C, Goldie SJ, Neumann PJ (2000) Cost-utility analyses of clinical preventive services: published ratios, 1976-1997. Am J Prev Med 19:15-23 (Pubitemid 30364993)
35. Dawson-Hughes B, Tosteson ANA, Melton LJ III, Baim S, Favus MJ, Khosla S, Lindsay RL (2008) Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the U.S. Osteoporos Int DOI 10.1007/s00198-008-0559-565
36. Schousboe JT, Ensrud KE, Nyman JA, Melton LJ 3rd, Kane RL (2005) Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J Am Geriatr Soc 53:1697-1704
37. Schousboe JT, Taylor BC, Fink HA, Kane RL, Cummings SR, Orwoll ES, Melton LJ 3rd, Bauer DC, Ensrud KE (2007) Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA 298:629-637 (Pubitemid 47236414)
38. King AB, Saag KG, Burge RT, Pisu M, Goel N (2005) Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment. Osteoporos Int 16:1545-1557 (Pubitemid 41790858)
39. Kraemer DF, Nelson HD, Bauer DC, Helfand M (2006) Economic comparison of diagnostic approaches for evaluating osteoporosis in older women. Osteoporos Int 17:68-76
40. Guyatt G, Baumann M, Pauker S, Halperin J, Maurer J, Owens DK, Tosteson AN, Carlin B, Gutterman D, Prins M, Lewis SZ, Schunemann H (2006) Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions froman American College of Chest Physicians task force. Chest 129:182-187 (Pubitemid 43265260)
41. Kanis JA, Johnell O, Odén A, Borgström F, Zethraeus N, De Laet C, Jönsson B (2004) The risk and burden of vertebral fractures in Sweden. Osteoporos Int 15:20-26 (Pubitemid 38252435)